Download Detection and Control of Epidemic Meningococcal Disease

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Sociality and disease transmission wikipedia , lookup

Herd immunity wikipedia , lookup

Neglected tropical diseases wikipedia , lookup

Transmission (medicine) wikipedia , lookup

Infection wikipedia , lookup

Vaccination wikipedia , lookup

Schistosomiasis wikipedia , lookup

Behçet's disease wikipedia , lookup

Kawasaki disease wikipedia , lookup

Neuromyelitis optica wikipedia , lookup

Rheumatoid arthritis wikipedia , lookup

Eradication of infectious diseases wikipedia , lookup

Ankylosing spondylitis wikipedia , lookup

Childhood immunizations in the United States wikipedia , lookup

Multiple sclerosis research wikipedia , lookup

Germ theory of disease wikipedia , lookup

Globalization and disease wikipedia , lookup

Infection control wikipedia , lookup

Meningococcal disease wikipedia , lookup

Transcript
Detection and Control
of Epidemic
Meningococcal Disease
Epidemiology
CDC
Men/Epidemiology/1
Centers for Disease
Control and
Prevention
Meningococcal Disease
Caused by Neisseria meningitidis, a
Gram-negative bacteria
Only major form of meningitis that causes
epidemics
Occurs throughout world, but is a severe
problem in "meningitis belt"
Early detection of epidemics saves lives
Men/Epidemiology/2
CDC
Centers for Disease
Control and
Prevention
"Meningitis Belt" in Africa
CDC
Men/Epidemiology/3
Centers for Disease
Control and
Prevention
"Meningitis Belt" Epidemics
Serogroups A & C Neisseria meningitidis
Begin in dry season
End when rainy season begins
Attacks rates can exceed 1% of population
Children and young adults most affected
70% of cases die (without treatment)
10% of cases die (with treatment)
Men/Epidemiology/4
CDC
Centers for Disease
Control and
Prevention
Clinical Disease
Due to Neisseria Meningitidis
Meningitis is most common presentation
fever, headache, stiff neck
bulging fontanelle in infants
cloudy cerebrospinal fluid (CSF)
responds well to antibiotics
Septicemia occurs in 10-20% of cases
fever, petechial or purpural rash, hypotension
seizures, coma possible
CSF may be cloudy or clear (normal appearing)
progresses rapidly
30% die - responds poorly to antibiotics
Men/Epidemiology/5
CDC
Centers for Disease
Control and
Prevention
Carriage and Transmission of
N. Meningitidis
Only humans carry N. meningitidis
Bacteria live in mucosa of nose and throat
Spread in oral secretions or respiratory droplets
Most persons who carry N. meningitidis have no
symptoms of disease
Not clear why some people develop disease, but
humoral immunity is important
Men/Epidemiology/6
CDC
Centers for Disease
Control and
Prevention
Factors Favoring Epidemic
Meningococcal Disease
Environmental Factors
Host Factors
Strain Characteristics
CDC
Men/Epidemiology/7
Centers for Disease
Control and
Prevention
Factors Favoring Epidemic
Meningococcal Disease
Environmental Factors
low rainfall and humidity
dust storms in harmattan?
damage to normal mucosal barriers?
CDC
Men/Epidemiology/8
Centers for Disease
Control and
Prevention
Factors Favoring Epidemic
Meningococcal Disease
Host Factors
Population immunity decreases risk
Individual immunity via carriage or
immunization decreases risk
Concurrent upper respiratory infection (URI)
may increase risk
CDC
Men/Epidemiology/9
Centers for Disease
Control and
Prevention
Factors Favoring Epidemic
Meningococcal Disease
Strain Characteristics
Serogroup A main is the main cause of
epidemics in Africa (some C)
Enzyme type -- III-1 clone
CDC
Men/Epidemiology/10
Centers for Disease
Control and
Prevention
Risk Factors During Epidemics
Associated with:
crowded living conditions
low socio-economic status
Possible associations?
concurrent URI (more studies needed)
nutritional status
Infection with HIV
apparently not risk factor for infection during epidemics
of serogroup A meningococcal disease
CDC
Men/Epidemiology/11
Centers for Disease
Control and
Prevention
Meningococcal Vaccine
Mass vaccination is only way to control
epidemics
Effective against serogroups A & C of N.
meningitidis
Poorly immunigenic in infants
Only short term protection in children less than
4-years-old
CDC
Men/Epidemiology/12
Centers for Disease
Control and
Prevention
Weekly Meningococcal Disease
Attack Rates Predict Epidemics
Attack rate exceeding 15 cases / 100,000 per week for two
consecutive weeks predicts a large epidemic
Best applied to populations of 30,000 to 100,000 persons
Rate of 15 / 100,000 per week for 2 weeks:
is low enough to detect an epidemic early, so that vaccination
will have impact
is high enough to avoid frequent false alarms
CDC
Men/Epidemiology/13
Centers for Disease
Control and
Prevention